NasdaqGS:AGIOBiotechs
Assessing Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Pullback
Event overview and recent stock context
Agios Pharmaceuticals (AGIO) has drawn attention after a recent share price pullback, with the stock down about 22% over the past month and modestly negative over the past 3 months.
See our latest analysis for Agios Pharmaceuticals.
That recent 22% one month share price pullback comes after a relatively flat 90 day share price return of about 1% decline and a modestly positive year to date share price return of 1.4%. At the same time, the 1 year total...